These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 33263002)
1. Molecular Defects in Friedreich's Ataxia: Convergence of Oxidative Stress and Cytoskeletal Abnormalities. Smith FM; Kosman DJ Front Mol Biosci; 2020; 7():569293. PubMed ID: 33263002 [TBL] [Abstract][Full Text] [Related]
2. Loss of filamentous actin, tight junction protein expression, and paracellular barrier integrity in frataxin-deficient human brain microvascular endothelial cells-implications for blood-brain barrier physiology in Friedreich's ataxia. Smith FM; Kosman DJ Front Mol Biosci; 2023; 10():1299201. PubMed ID: 38274097 [No Abstract] [Full Text] [Related]
3. Frataxin-deficient human brain microvascular endothelial cells lose polymerized actin and are paracellularly permeable -implications for blood-brain barrier integrity in Friedreich's Ataxia. Smith FM; Kosman DJ bioRxiv; 2023 Feb; ():. PubMed ID: 36798283 [TBL] [Abstract][Full Text] [Related]
6. Novel Nrf2-Inducer Prevents Mitochondrial Defects and Oxidative Stress in Friedreich's Ataxia Models. Abeti R; Baccaro A; Esteras N; Giunti P Front Cell Neurosci; 2018; 12():188. PubMed ID: 30065630 [TBL] [Abstract][Full Text] [Related]
7. Heart disease in Friedreich's ataxia. Hanson E; Sheldon M; Pacheco B; Alkubeysi M; Raizada V World J Cardiol; 2019 Jan; 11(1):1-12. PubMed ID: 30705738 [TBL] [Abstract][Full Text] [Related]
8. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810 [TBL] [Abstract][Full Text] [Related]
9. An Overview of the Ferroptosis Hallmarks in Friedreich's Ataxia. Turchi R; Faraonio R; Lettieri-Barbato D; Aquilano K Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33126466 [TBL] [Abstract][Full Text] [Related]
10. Correlation between frataxin expression and contractility revealed by in vitro Friedreich's ataxia cardiac tissue models engineered from human pluripotent stem cells. Wong AO; Wong G; Shen M; Chow MZ; Tse WW; Gurung B; Mak SY; Lieu DK; Costa KD; Chan CW; Martelli A; Nabhan JF; Li RA Stem Cell Res Ther; 2019 Jul; 10(1):203. PubMed ID: 31286988 [TBL] [Abstract][Full Text] [Related]
11. Efficient attenuation of Friedreich's ataxia (FRDA) cardiomyopathy by modulation of iron homeostasis-human induced pluripotent stem cell (hiPSC) as a drug screening platform for FRDA. Lee YK; Lau YM; Ng KM; Lai WH; Ho SL; Tse HF; Siu CW; Ho PW Int J Cardiol; 2016 Jan; 203():964-71. PubMed ID: 26625322 [TBL] [Abstract][Full Text] [Related]
12. The Role of Iron in Friedreich's Ataxia: Insights From Studies in Human Tissues and Cellular and Animal Models. Llorens JV; Soriano S; Calap-Quintana P; Gonzalez-Cabo P; Moltó MD Front Neurosci; 2019; 13():75. PubMed ID: 30833885 [TBL] [Abstract][Full Text] [Related]
13. Friedreich's ataxia: past, present and future. Marmolino D Brain Res Rev; 2011 Jun; 67(1-2):311-30. PubMed ID: 21550666 [TBL] [Abstract][Full Text] [Related]
14. Emerging antioxidant therapies in Friedreich's ataxia. Edzeamey FJ; Ramchunder Z; Pourzand C; Anjomani Virmouni S Front Pharmacol; 2024; 15():1359618. PubMed ID: 38379897 [TBL] [Abstract][Full Text] [Related]
15. Cis-silencing of PIP5K1B evidenced in Friedreich's ataxia patient cells results in cytoskeleton anomalies. Bayot A; Reichman S; Lebon S; Csaba Z; Aubry L; Sterkers G; Husson I; Rak M; Rustin P Hum Mol Genet; 2013 Jul; 22(14):2894-904. PubMed ID: 23552101 [TBL] [Abstract][Full Text] [Related]
16. Progressive mitochondrial protein lysine acetylation and heart failure in a model of Friedreich's ataxia cardiomyopathy. Stram AR; Wagner GR; Fogler BD; Pride PM; Hirschey MD; Payne RM PLoS One; 2017; 12(5):e0178354. PubMed ID: 28542596 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of gene expression patterns in Friedreich's ataxia fibroblasts by RNA sequencing reveals altered levels of protein synthesis factors and solute carriers. Napierala JS; Li Y; Lu Y; Lin K; Hauser LA; Lynch DR; Napierala M Dis Model Mech; 2017 Nov; 10(11):1353-1369. PubMed ID: 29125828 [TBL] [Abstract][Full Text] [Related]
18. Actin glutathionylation increases in fibroblasts of patients with Friedreich's ataxia: a potential role in the pathogenesis of the disease. Pastore A; Tozzi G; Gaeta LM; Bertini E; Serafini V; Di Cesare S; Bonetto V; Casoni F; Carrozzo R; Federici G; Piemonte F J Biol Chem; 2003 Oct; 278(43):42588-95. PubMed ID: 12915401 [TBL] [Abstract][Full Text] [Related]
19. Ferroptosis as a Novel Therapeutic Target for Friedreich's Ataxia. Cotticelli MG; Xia S; Lin D; Lee T; Terrab L; Wipf P; Huryn DM; Wilson RB J Pharmacol Exp Ther; 2019 Apr; 369(1):47-54. PubMed ID: 30635474 [TBL] [Abstract][Full Text] [Related]
20. Assessment of cell-free levels of iron and copper in patients with Friedreich's ataxia. Pathak D; Srivastava AK; Gulati S; Rajeswari MR Biometals; 2019 Apr; 32(2):307-315. PubMed ID: 30874991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]